• Users Online: 109
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2017  |  Volume : 14  |  Issue : 3  |  Page : 105-111

Flaxseed oil: an emerging nutraceutical decimates cisplatin-induced submandibular salivary glands damage in rats


1 Department of Oral Biology, Faculty of Dentistry, Tanta University, Tanta, Egypt
2 Department of Oral Pathology, Faculty of Dentistry, Tanta University, Tanta, Egypt

Correspondence Address:
Doaa A Labah
19, Omar Ebn El Khatab Street, Villal El Gamah, El Zagazig
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/tdj.tdj_7_17

Rights and Permissions

Objective The study aimed to investigate the capability of flaxseed oil (FXO) to alleviate the degenerative effect of chemotherapy with cisplatin (CP) on rats' submandibular salivary glands (SMGs). Materials and methods Rats were allocated equally into four groups: control, CP-treated, FXO-treated, and CP-FXO-treated groups. Rats of third and fourth groups were orally given a daily dose of FXO. After 10 days, rats in second and fourth groups were injected with a single dose of CP. After rat sacrifice, samples of SMGs were processed for histological, ultrastructural study beside immunohistochemical staining for Ki67 and vascular endothelial growth factor (VEGF) expressions. Analysis of variance was used to compare Ki67 and VEGF expressions between groups. Results The SMGs of CP group showed abnormal architecture when compared with control and FXO groups. CP group treated with FXO revealed architecture improvement in their SMGs. Immunohistochemical study revealed significant decrease in Ki67 and VEGF expressions in CP rats. However, CP group treated with FXO simulated control group in both Ki67 and VEGF expressions. Conclusion CP administration caused deleterious effects on rats' SMGs. However, dietary consumption of FXO was able to ameliorate CP effects. Hence, FXO intake is recommended simultaneously during chemotherapy with CP.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed200    
    Printed5    
    Emailed0    
    PDF Downloaded57    
    Comments [Add]    

Recommend this journal